Variant report
Variant | esv3403808 |
---|---|
Chromosome Location | chr16:72753222-72753833 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543803352 | chr16:72753243-72753244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552006295 | chr16:72753298-72753299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7195014 | chr16:72753299-72753300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368874863 | chr16:72753303-72753304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375414683 | chr16:72753395-72753396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113894268 | chr16:72753593-72753594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs111566580 | chr16:72753594-72753595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112265932 | chr16:72753595-72753596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562147931 | chr16:72753666-72753667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545015001 | chr16:72753689-72753690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529703904 | chr16:72753722-72753723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541543713 | chr16:72753740-72753741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192453261 | chr16:72753774-72753775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs377535535 | chr16:72753789-72753790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547210889 | chr16:72753820-72753821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571842168 | chr16:72753828-72753829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543990688 | chr16:72753832-72753833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chordoma | 18071362 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Infiltrating lobular breast cancer | 19191266 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ependymoma | 18628472 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:72746400-72760800 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr16:72746600-72755400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr16:72747800-72757600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr16:72749400-72756200 | Weak transcription | Ovary | ovary |
5 | chr16:72750000-72755400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr16:72750000-72755800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr16:72750400-72755600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr16:72750600-72757200 | Weak transcription | Dnd41 | blood |
9 | chr16:72750600-72763200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr16:72750800-72753400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr16:72751800-72755600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |